Combined immunosuppressive activities of delta-9-tetrahydrocannabinol and murine retrovirus.
Specter
S
S
Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa 33612.
Lancz
G
G
Westrich
G
G
Friedman
H
H
D000818:Animals; D003864:Depression, Chemical; D004198:Disease Susceptibility / Q000276:immunology; D013759:Dronabinol / Q000494:pharmacology*; D005260:Female; D005622:Friend murine leukemia virus / Q000276:immunology*; D006561:Herpes Simplex / Q000150:complications; D007108:Immune Tolerance / Q000187:drug effects*; D007153:Immunologic Deficiency Syndromes / Q000209:etiology* / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D009894:Opportunistic Infections / Q000150:complications; D011086:Polycythemia / Q000150:complications / Q000276:immunology*; D014412:Tumor Virus Infections / Q000150:complications / Q000276:immunology*
D008934:Mitogens; D013759:Dronabinol